It is with great honor and pleasure to announce the recipient of the 2020 Sue Rosenau Legacy Award to Dr. Philip Farrell. Dr. Farrell, a light-hearted and jovial physician, has spent the past 4-decades working to provide the best quality of life to those diagnosed with Cystic Fibrosis. His leadership and research in newborn screening, clinical care, and assessing the added value of whole genome sequencing is a model for others to follow working in the rare disease space.
Dr. Ellen Wald, MD, Chair and Professor of the University of WI Department of Pediatrics states, “I’ve had the pleasure of working with Dr. Farrell for over 14 years at the U of WI– Madison School of Medicine and Public Health, but his tremendous impact to our school’s research, medical education, and pediatric clinical care extend decades before our time together. He is a dedicated physician-scientist, whose outstanding research on CF paved the way for nationwide CF newborn screening. His current research into the origin of CF and his commitment to quality in the operation of newborn screening programs will no doubt further pediatric clinical care and profoundly expand our understanding of CF.”
TLOAF selected Dr. Farrell because his work and commitments align with the Sue Rosenau Legacy Award conditions. The purpose of this award is to recognize an inspirational leader who collectively creates lasting change and measurable differences in one or more areas of our mission. Dr. Farrell has delivered extraordinary contributions, worked to propel progress in those living with CF, and continuously supports other CF work whenever possible; a replica of the late-Co-Founder, Sue Rosenau.
Full press release available here